Successful treatment of vancomycin-resistant Enterococcus endocarditis with oral linezolid

被引：69

作者：

Babcock, HM

Ritchie, DJ

Christiansen, E

Starlin, R

Little, R

Stanley, S

机构：

[1] Washington Univ, Sch Med, Dept Internal Med, Div Infect Dis, St Louis, MO 63110 USA

[2] Barnes Jewish Hosp, St Louis, MO 63110 USA

[3] St Louis Coll Pharm, St Louis, MO USA

来源：

CLINICAL INFECTIOUS DISEASES | 2001年 / 32卷 / 09期

关键词：

D O I：

10.1086/319986

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

We report a case of vancomycin-resistant Enterococcus faecium endocarditis that failed to respond to sequential monotherapy with chloramphenicol and quinupristin/dalfopristin but was successfully treated with oral linezolid.

引用

页码：1373 / 1375

页数：3

共 9 条

[1] Comparative in vitro and bactericidal activity of oxazolidinone antibiotics against multidrug-resistant enterococci [J].

Bostic, GD ;

Perri, MB ;

Thal, LA ;

Zervos, MJ .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1998, 30 (02) :109-112

[2] Use of linezolid, an oxazolidinone, in the treatment of multidrug-resistant gram-positive bacterial infections [J].

Chien, JW ;

Kucia, ML ;

Salata, RA .

CLINICAL INFECTIOUS DISEASES, 2000, 30 (01) :146-151

[3] Therapy with RP 59500 (quinupristin/dalfopristin) for prosthetic valve endocarditis due to Enterococci with VanA/VanB resistance patterns [J].

Furlong, WB ;

Rakowski, TA .

CLINICAL INFECTIOUS DISEASES, 1997, 25 (01) :163-164

[4] Association between resistance to vancomycin and death in cases of Enterococcus faecium bacteremia [J].

Garbutt, JM ;

Ventrapragada, M ;

Littenberg, B ;

Mundy, LM .

CLINICAL INFECTIOUS DISEASES, 2000, 30 (03) :466-472

[5] Epidemiologic trends in nosocomial and community-acquired infections due to antibiotic-resistant gram-positive bacteria: The role of streptogramins and other newer compounds [J].

Jones, RN ;

Low, DE ;

Pfaller, MA .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1999, 33 (02) :101-112

[6] Treatment of endocarditis due to vancomycin-resistant Enterococcus faecium with quinupristin/dalfopristin, doxycycline, and rifampin:: A synergistic drug combination [J].

Matsumura, S ;

Simor, AE .

CLINICAL INFECTIOUS DISEASES, 1998, 27 (06) :1554-1556

[7] Successful treatment of vancomycin-resistant Enterococcus faecium bacteremia with linezolid after failure of treatment with synercid (quinupristin/dalfopristin) [J].

McNeil, SA ;

Clark, NM ;

Chandrasekar, PH ;

Kauffman, CA .

CLINICAL INFECTIOUS DISEASES, 2000, 30 (02) :403-404

[8] Successful treatment of persistent vancomycin-resistant Enterococcus faecium bacteremia with linezolid and gentamicin [J].

Noskin, GA ;

Siddiqui, F ;

Stosor, V ;

Kruzynski, J ;

Peterson, LR .

CLINICAL INFECTIOUS DISEASES, 1999, 28 (03) :689-690

[9] Comparative in vitro activities and postantibiotic effects of the oxazolidinone compounds eperezolid (PNU-100592) and linezolid (PNU-100766) versus vancomycin against Staphylococcus aureus, coagulase-negative staphylococci, Enterococcus faecalis, and Enterococcus faecium [J].

Rybak, MJ ;

Cappelletty, DM ;

Moldovan, T ;

Aeschlimann, JR ;

Kaatz, GW .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (03) :721-724

← 1 →